Showing results (141-150 of 527) with videos related to

Sort By:
Pageof 53
European Journal of Clinical Pharmacology|April 7, 1999
Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal functionH Buter, G Y Navis, A J Woittiez, et al.
Clinical Science (London, England : 1979)|May 1, 1996
Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosisF H Wapstra, H Van Goor, G Navis, et al.
Burns : Journal of the International Society for Burn Injuries|July 4, 2007
Non-pharmacological nursing interventions for procedural pain relief in adults with burns: a systematic literature reviewA E E de Jong, E Middelkoop, A W Faber, et al.
Kidney International|July 1, 1987
Reduction of proteinuria by angiotensin converting enzyme inhibitionJ E Heeg, P E de Jong, G K van der Hem, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 1998
Sample dilution: a methodological pitfall in the measurement of tissue but not serum ace-activityJ Koiter, G Navis, P E de Jong, et al.
The American Journal of Physiology|October 1, 1995
Noninvasive measurement of intrarenal blood flow distribution: kinetic model of renal 123I-hippuran handlingW M Janssen, H Beekhuis, R de Bruin, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1992
Atrial natriuretic factor influences renal diurnal rhythm in essential hypertensionW M Janssen, D de Zeeuw, G K van der Hem, et al.
Kidney International|October 1, 1991
Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibitionJ E Heeg, P E de Jong, G K van der Hem, et al.
Journal of Hypertension|April 1, 1994
Renal tubular sensitivity to atrial natriuretic factor in essential hypertensionW M Janssen, D de Zeeuw, G K van der Hem, et al.
Pageof 53